Tumor immune microenvironment remodeling predicts response to checkpoint inhibitor therapy

Study limitation reported by the research below: “Study design is observational/atlas-based; the 'practice changing' flag reflects translational potential of the 59-gene signature validated across 19 cohorts, but prospective clinical trials have not yet been conducted.”